On July 18, the 2023 National Conference on Scientific Supervision of Traditional Chinese Medicine, approved by the National Medical Products Administration, hosted by China Health Media Group and co sponsored by the Shanghai Municipal Drug Administration and the National Medical Products Administration Drug Evaluation and Inspection Yangtze River Delta Branch, opened in Shanghai. The theme of the conference is "focusing on the supervision of quality standards of traditional Chinese medicine, strengthening the integration and innovation of traditional Chinese medicine and western medicine, and promoting the Chinese path to modernization drug supervision practice with the scientific supervision of traditional Chinese medicine". Traditional Chinese medicine is a treasure of Chinese civilization and has made tremendous contributions to the reproduction and development of the Chinese nation for thousands of years. It is an indispensable and important part of the construction of a healthy China. Zhao Junning, a member of the Party Group and Deputy Director of the National Drug Administration, stated at the meeting that in recent years, under the strong leadership of the Party Central Committee and the State Council, with strong support from various regions and departments, drug regulatory departments have adhered to integrity and innovation, insisted on clarifying the efficacy of traditional Chinese medicine, vigorously encouraged the research and development of new Chinese medicine drugs, continuously improved the regulatory system of traditional Chinese medicine, and built a solid quality and safety supervision system of traditional Chinese medicine, Promoting the inheritance, innovation and development of traditional Chinese medicine has entered the "fast lane". With the increasing policy support from the Party Central Committee and the State Council to promote the inheritance and innovation of traditional Chinese medicine, the development of traditional Chinese medicine inheritance and innovation has ushered in a new historical development opportunity. We should deeply grasp the trend of historical development, accurately grasp the stage of historical development, and put the promotion of the inheritance and innovative development of traditional Chinese medicine into the great practice of promoting Chinese path to modernization to plan and deploy, so as to truly make the Chinese national cultural treasure glow with new brilliance. The safety supervision and inheritance of traditional Chinese medicine are currently in a period of high-quality development strategic opportunities, and it is urgent for all parties to brainstorm and work together to promote this grand event. This conference has high specifications, multiple fields, and strong professionalism, closely following the forefront of technology, focusing on industry needs, and heavyweight guests sharing insights. Zhao Junning gave a keynote speech entitled "Construction and Practice of Chinese path to modernization Scientific Supervision System of Traditional Chinese Medicine", introducing the top-level design, systematic thinking and supervision practice of the State Food and Drug Administration on the supervision of traditional Chinese medicine in recent years. Zhang Boli, academician of the Member of the Chinese Academy of Engineering, Huang Luqi, academician of the Member of the Chinese Academy of Engineering, Yan Shiyun, a master of traditional Chinese medicine, Cheng Jing, academician of the Member of the Chinese Academy of Engineering, Chen Kaixian, academician of the CAS Member, Wang Qi, academician of the Member of the Chinese Academy of Engineering, Jiang Jiandong, academician of the Member of the Chinese Academy of Engineering, Xiao Wei, academician of the Member of the Chinese Academy of Engineering, and Lin Guoqiang, academician of the CAS Member made keynote speeches, reviewing the major historical changes in the research and development of new Chinese medicines, and exchanging the status quo and prospects of Chinese medicine innovation based on clinical value, Elaborate on promoting the modernization of traditional Chinese medicine, data-driven innovation of traditional Chinese medicine, and high-quality scientific development around key scientific issues of traditional Chinese medicine, "clarify and explain the efficacy of traditional Chinese medicine", traditional Chinese medicine standards and quality control throughout the process, and share opinions on the high-quality development of the traditional Chinese medicine industry, the standardization and innovation of traditional Chinese medicine, and the use of modern technology to assist the innovative development of traditional Chinese medicine. The meeting also released the Policies, Regulations and Technical Guidelines on the Supervision of Chinese Traditional Medicine and the 2022 National Bluebook on the Supervision of Chinese Traditional Medicine. The "Policy, Regulations, and Technical Guidelines for the Supervision of Traditional Chinese Medicine in China" is a new tool book that combines the interpretation of traditional Chinese medicine regulatory policies and research technical guidelines. It comprehensively and systematically summarizes and sorts out the policies, regulations, and technical regulations for the entire industry chain and lifecycle of traditional Chinese medicine, taking into account the regulatory responsibilities, emerging technological challenges, and industrial development needs of traditional Chinese medicine